RIO DE JANEIRO (Reuters) - Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or ...
Amid the push to get the COVID-19 vaccine to many as possible to stem the pandemic, a new variant of the coronavirus that exploded in Brazil and has since been reported in the U.S. is causing concern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results